ŞÇŞevki Çelen

Şevki Çelen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Şevki Çelen has a total of 190 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of the Gustave Roussy Immune Score in intrahepatic cholestasis of pregnancy and adverse perinatal outcomes: a retrospective case–control study

    by Ahmet Arif Filiz, Kubilay Çanga, Gülşan Karabay, Recep Taha Ağaoğlu, Özgür Volkan Akbulut, Ahmet Kurt, Alper İçAlan, Dinçer Sümer, S. Ahmet Erol, Şevki Çelen

    Aims: To evaluate the Gustave Roussy Immune (GRIm) score and its individual components in women with intrahepatic cholestasis of pregnancy, and to explore their discriminatory performance for intrahepatic cholestasis of pregnancy and composite adverse perinatal outcomes. Methods: This retrospective case–control study included 130 females with singleton pregnancies in the third trimester: 65 diagnosed with intrahepatic cholestasis of pregnancy and 65 controls. Females with conditions that could substantially affect hepatic, inflammatory, or hematologic parameters were excluded. The GRIm score was calculated by assigning one point for each of the following: serum lactate dehydrogenase above 245 U/L, serum albumin below 35 g/L, and a neutrophil-to-lymphocyte ratio above 6. Group comparisons and receiver operating characteristic curve analyses were performed. Optimal cut-offs were determined using the Youden index. Results: The median GRIm score was higher in females with intrahepatic cholestasis of pregnancy than in controls [1 (1-2) vs. 0 (0–1); p

  • Open Access

    Placental NLRP3 expression across placenta accreta spectrum, placenta previa, and other non-PAS placental pathologies: an immunohistochemical study

    by Dinçer Sümer, Hitay Cemre Metindoğan, Firdevs Şahin Duran, Ahmet Arif Filiz, Özgür Volkan Akbulut, Büşra Seçilir, Furkan Akın, Zehra Yılmaz, Şevki Çelen, Ali Çağlar

    Aims: Placenta accreta spectrum (PAS) is characterized by abnormal trophoblast invasion and is associated with substantial maternal morbidity. This study aimed to evaluate placental NLRP3 protein expression across PAS, placenta previa, and other non-PAS placental pathologies. Methods: This retrospective study included 52 placental specimens: 26 PAS cases, 11 placenta previa cases, and 15 other non-PAS placental pathologies. NLRP3 expression was assessed immunohistochemically using a semi-quantitative scoring system. Logistic regression and receiver operating characteristic (ROC) analyses were performed to evaluate the association of NLRP3 with PAS. Results: NLRP3 staining scores differed significantly across the three study groups (p=0.036). However, none of the pairwise comparisons remained statistically significant after Bonferroni correction, although PAS showed a trend toward higher NLRP3 expression than other non-PAS placental pathologies before correction (uncorrected p=0.018), these findings should be considered exploratory. In univariable logistic regression, higher NLRP3 expression was associated with PAS (OR 1.318, 95% CI 1.041–1.669, p=0.022). After adjustment, the number of previous cesarean deliveries remained independently associated with PAS (aOR 8.621, 95% CI 2.325–31.959, p=0.001), whereas NLRP3 expression showed a borderline independent association (aOR 1.480, 95% CI 0.988–2.216, p=0.057). ROC analysis demonstrated modest discriminative performance in this cohort (AUC 0.685, 95% CI 0.540–0.830, p=0.022). Conclusion: Placental NLRP3 expression showed a trend toward higher expression in PAS but pairwise differences did not remain statistically significant after Bonferroni correction. Accordingly, these findings should be considered exploratory and hypothesis-generating. Although NLRP3 may be involved in inflammatory pathways related to abnormal placentation, its diagnostic performance was modest and its independent predictive value appeared limited after adjustment for established clinical risk factors.

  • Fragmented QRS and P-Wave Dispersion in Pregnancies Complicated by Systemic Lupus Erythematosus

    by Aziz Kından, Can Ozan Ulusoy, Ahmet Kurt, Çağatay Tunca, Furkan Enes Solak, Furkan Akın, Özgür Volkan Akbulut, Sinem Ece Kından, Kubilay Canga, Recep Taha Ağaoğlu, et al.

  • Maternal Plasma Afamin Levels in Pregnancies Complicated by Fetal Growth Restriction and Their Association With Doppler Markers of Placental Dysfunction

    by Emrah Göçer, Kadriye Yakut Yücel, Cemal Ünlü, Harika Göçer, Şevki Çelen

    Aim: To compare maternal plasma afamin between pregnancies with fetal growth restriction (FGR) defined by fetal biometry and healthy controls, to test whether the cross‐sectional association between afamin and gestational age differs in FGR, and to examine associations with Doppler indices. Methods: In this prospective study, 84 women assessed at 28–40 weeks (40 FGR, 44 controls) underwent same‐day maternal blood sampling and umbilical‐, middle‐cerebral‐, and uterine‐artery Doppler. FGR was defined by an estimated fetal weight or abdominal circumference below the 5th percentile. Plasma afamin was measured by enzyme‐linked immunosorbent assay. Analyses included a group‐by‐gestational‐age interaction model, multivariable logistic regression, adjusted partial correlations, and receiver operating characteristic analysis. Results: Afamin was higher in FGR than controls (109.6 ± 5.8 vs. 98.2 ± 9.4 mg/L; p < 0.0001), persisting after adjustment (adjusted difference 11.2 mg/L). In controls, afamin was strongly associated with gestational age ( r = 0.95), whereas in FGR it was not ( r = −0.03); the group‐by‐gestational‐age interaction was significant ( p < 0.0001). Afamin was associated with FGR after adjustment (odds ratio 4.99 per 5 mg/L), an effect concentrated before 34 weeks. Pooled afamin–Doppler (Spearman) correlations did not remain significant after adjustment for group. Afamin did not correlate with body mass index. The area under the curve was 0.837. Conclusions: In biometrically defined FGR, plasma afamin was elevated and, unlike in controls, was not associated with gestational age. Afamin was associated with FGR after covariate adjustment, but its strength varied with gestational age; these cross‐sectional, exploratory findings require validation before clinical use.

  • Open Access

    Peak Total Bile Acids and Adverse Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy: A Retrospective Cohort Study with Threshold Analysis

    by Türkan Dikici Aktaş, Özgür Volkan Akbulut, Bengisu Elüstü Çakır, Emel Özalp, Belgin Savran Üçok, Şevki Çelen

    Background: Peak total bile acids guide management of intrahepatic cholestasis of pregnancy (ICP), potentially influencing observed outcomes. We examined their association with a composite adverse perinatal outcome (CAPO) excluding preterm delivery. Methods: This retrospective cohort included 280 singleton pregnancies with ICP delivered at a tertiary hospital between January 2023 and May 2026. Peak bile acids were categorized as p < 0.001). In the ≥100 µmol/L group, the exact 95% confidence interval for CAPO was 54.9–90.6%. The apparent area under the curve was 0.700 (95% confidence interval 0.625–0.772). The 61.3 µmol/L threshold yielded 50.7% sensitivity and 83.9% specificity. Peak bile acids per 10 µmol/L (adjusted odds ratio 1.20, 95% confidence interval 1.11–1.31) and hypertensive disorders (3.27, 1.30–8.23) were independently associated with CAPO. Conclusions: Peak bile acids showed moderate discrimination within this managed cohort. The ≥100 µmol/L subgroup had higher morbidity but imprecise estimates. The same-cohort-derived 61.3 µmol/L threshold is exploratory and requires independent validation; it should not determine delivery timing.

  • Outcome-Based Comparison of SMFM and Delphi/ISUOG Criteria for Late-Onset Fetal Growth Restriction: A Retrospective Cohort Study

    by Berna Seyhan, Hasan Mert Başbuğa, Hamza Arda Açıkgöz, Özgür Volkan Akbulut, Şevki Çelen

    Background: Differentiating late-onset fetal growth restriction from constitutional smallness can be challenging in routine practice. The Society for Maternal-Fetal Medicine (SMFM) primarily defines FGR using fetal biometric cutoffs, whereas the Delphi/International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) approach also takes growth trajectory and Doppler findings into account.Objective: We aimed to compare the level of agreement between the SMFM and Delphi/ISUOG definitions and to assess how each performed in relation to perinatal outcomes within the same late-gestation cohort.Methods: We reviewed 280 singleton pregnancies managed at a single center between January 2023 and May 2026. All pregnancies were evaluated at 32 weeks of gestation or later. Each case was classified according to both the SMFM and Delphi/ISUOG criteria. The primary endpoint was a composite adverse perinatal outcome.Secondary outcomes were birth weight below the 10th and 3rd percentiles. We calculated diagnostic performance with 95% confidence intervals, Cohen kappa agreement, and exact McNemar tests.Results: The SMFM definition classified 36 pregnancies (12.9%) as fetal growth restriction, compared with 15 (5.4%) by Delphi/ISUOG. Twelve pregnancies met both definitions, 24 met only SMFM, and 3 met only Delphi/ISUOG. Agreement was moderate (kappa 0.43; 95% confidence interval 0.24-0.59). The composite outcome occurred in 37 cases (13.2%). SMFM sensitivity and specificity for this outcome were 16.2% and 87.7%; corresponding Delphi/ISUOG values were 10.8% and 95.5%. Delphi/ISUOG was more specific (p

  • Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index and Postpartum Haemorrhage after Caesarean Delivery

    by Alperen Aksan, Sadullah Özkan, Murat Levent Dereli, Şevki Çelen, Ali Çağlar, Yaprak Ustun

    Purpose: Postpartum haemorrhage (PPH) is a leading cause of maternal death, yet a simple preoperative marker of risk is lacking. The aspartate aminotransferase-to platelet ratio index (APRI) has been linked to adverse outcomes in non-hepatic surgery and in pregnancy complications. We examined whether it predicts PPH after caesarean delivery.Materials and Methods: This retrospective case–control study reviewed caesarean deliveries at a tertiary hospital (2021–2022). Cases were 297 women who developed PPH (bleeding requiring transfusion and/or intervention for haemostasis); controls were 301 who needed neither. APRI was calculated from AST and platelet values obtained within 48 hours before delivery. Discrimination was assessed by ROC analysis in the a priori orientation (higher APRI hypothesised to indicate PPH), against haemoglobin, haematocrit, and platelet count, and by multivariable logistic regression adjusting for established risk factors.Results: Preoperative haemoglobin and haematocrit were lower in the PPH group (10.4 vs 11.9 g/dL; 32.0% vs 35.0%; both p

  • Open Access

    Labor Management and Neonatal Outcomes in Term Isolated Oligohydramnios Defined by the Single Deepest Vertical Pocket: A Retrospective Cohort Study

    by Emel Özalp, Kubilay Çanga, Özgür Volkan Akbulut, Türkan Dikici Aktaş, Şevki Çelen

    Background/Objectives: The clinical significance of isolated oligohydramnios at term may depend on the measurement method used. We assessed whether isolated oligohydramnios at term, defined by a single deepest vertical pocket (SDVP) below 2 cm, is associated with labor management, primary cesarean delivery, and short-term neonatal outcomes. Methods: This retrospective cohort study included 328 singleton pregnancies delivered at 37 + 0 to 41 + 6 weeks at a tertiary center between January 2023 and May 2026. All 128 exposed pregnancies met SDVP < 2 cm; 72 AFI-only cases with SDVP ≥ 2 cm were excluded from the primary analysis. The control group comprised 200 low-risk term pregnancies with SDVP ≥ 2 cm. Primary cesarean outcomes were evaluated among women without a previous cesarean delivery. Multivariable logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: Labor induction was more frequent with SDVP-defined isolated oligohydramnios than with normal fluid (75.0% vs. 29.0%; p < 0.001). Among induced women, admission Bishop score, labor duration, and failed-induction rate were similar (6.3% vs. 5.2%; p = 1.000). Overall cesarean delivery, including repeat procedures, occurred in 30.5% versus 19.0% (p = 0.017). Primary cesarean delivery occurred in 25.8% and 18.5% (aOR, 1.67; 95% CI, 0.94–2.99), whereas primary cesarean delivery for fetal distress was more frequent (14.2% vs. 5.6%; aOR, 2.50; 95% CI, 1.05–5.94). Composite neonatal morbidity did not differ significantly (12.5% vs. 9.0%; aOR, 1.31; 95% CI, 0.61–2.78), nor did neonatal intensive care unit admission, cord pH, or neonatal death. Conclusions: At term, SDVP-defined isolated oligohydramnios was associated with more labor induction, a higher crude overall cesarean rate, and more primary cesarean delivery for fetal distress. No statistically significant adjusted association was detected for primary cesarean delivery or composite neonatal morbidity; the confidence intervals do not establish equivalence or exclude clinically important differences.

  • Open Access

    Evaluation of fetal frontal lobe development and Evans index in pregnancies complicated by gestational diabetes mellitus: prospective comparative observational study

    by Kubilay Çanga, Recep Taha Ağaoğlu, Özgür Volkan Akbulut, Dinçer Sümer, Seyit Ahmet Erol, Şevki Çelen

  • Open Access

    Assessment of albumin-related inflammatory indices in preeclampsia and their relationship with composite adverse perinatal outcomes

    by Aykut Kından, Goncagül Kından, Dilara Sarikaya Kurt, Ayberk Çakır, Özgür Volkan Akbulut, Şevki Çelen

    Background: Preeclampsia is characterized by systemic inflammation, endothelial dysfunction, and multi-organ involvement, contributing to increased risk of adverse perinatal outcomes. Albumin-based inflammatory and nutritional indices have recently gained interest as easily accessible biomarkers in high-risk pregnancies. This study aimed to compare albumin-related indices between preeclamptic and normotensive pregnancies and to evaluate their predictive value for composite adverse perinatal outcomes (CAPO) in preeclampsia. Methods: This retrospective case–control study included 186 preeclamptic patients and 186 healthy controls matched for maternal age, BMI, gravidity, and gestational age. Laboratory parameters measured at delivery and calculated indices (NAR, FAR, sACR, HALP, and BAR) were compared. The preeclampsia cohort was further classified into CAPO (+) and CAPO (–) groups. Logistic regression models were used to identify independent predictors of CAPO, and receiver operating characteristic (ROC) analysis assessed predictive performance. Results: Albumin-based indices differed significantly between preeclamptic and healthy pregnancies, with higher NAR, FAR, and BAR values and lower sACR levels in the preeclampsia group (all p < 0.001). Among preeclamptic patients, CAPO developed in 44.1% ( n = 82). CAPO (+) patients demonstrated higher NAR, BAR, and HALP values and lower sACR levels compared to CAPO (–) patients. In multivariable logistic regression, only the blood urea nitrogen-to-albumin ratio (BAR) remained independently associated with CAPO (aOR = 1.157, p = 0.015). BAR demonstrated moderate discriminative performance for CAPO (AUC = 0.718; cut-off > 0.61; sensitivity 67.1%; specificity 69.2%; p < 0.001). Conclusion: All albumin-based indices showed significant alterations in preeclampsia; however, only BAR independently predicted adverse perinatal outcomes. BAR is a simple, inexpensive biomarker derived from routine laboratory parameters and may support risk stratification and neonatal outcome prediction in preeclamptic pregnancies. Prospective multicenter studies are warranted to validate its clinical applicability.